Beginning of a new era of synthetic messenger RNA therapeutics: Comprehensive insights on mRNA drug design, development and applications
Saumya Nishanga Heendeniya, Suxiang Chen, Saadia Bhatti, Qurat Ul Ain Zahra, Kamal Rahimizadeh, Bal Hari Poudel, Stephen D. Wilton, Rakesh N. Veedu
TL;DR
This review explores how mRNA therapeutics, like those used in the SARS-CoV-2 vaccine, are being developed for a range of medical applications due to their safety and versatility.
Contribution
The paper provides a comprehensive overview of mRNA drug design, development, and therapeutic applications, highlighting recent advancements and strategies.
Findings
mRNA therapeutics offer safety due to their non-integration with the host genome.
Biomodifications and chemical advancements have improved mRNA stability and reduced immunogenicity.
mRNA strategies include protein replacement, immune modulation, and cellular modulation for diverse therapeutic uses.
Abstract
Messenger RNA (mRNA) therapeutics have significantly transformed contemporary medicine, particularly through their role as the active component in the SARS-CoV-2 vaccine. This remarkable achievement is the culmination of extensive research conducted over many years by scientists. The widespread administration of the COVID-19 vaccine has further accelerated research into the precise therapeutic potential of mRNA technologies. Since mRNA doesn’t integrate with the host genome, the safety and versatility of mRNA-based therapeutics make them an iconic candidate in targeted therapies. Due to a surge in innovation efforts, biomodification of the molecular signatures of mRNAs like the 5′cap, untranslated regions (UTRs), and the poly(A) tail are being developed to increase translation efficacy. Recent advancements in chemical modifications, codon optimization techniques, and targeted delivery…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRNA Interference and Gene Delivery · RNA and protein synthesis mechanisms · RNA Research and Splicing